D
Spero Therapeutics, Inc. SPRO
$1.87 $0.010.54% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -58.99% -59.83% -53.77% 37.01% 118.43%
Total Other Revenue -- -- -- -- --
Total Revenue -58.99% -59.83% -53.77% 37.01% 118.43%
Cost of Revenue 28.96% 69.77% 95.90% 166.67% 122.56%
Gross Profit -296.98% -308.07% -302.20% -64.92% 105.72%
SG&A Expenses 5.79% 1.89% -7.24% -9.90% -11.11%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 7.52% 40.14% 56.46% 42.30% 44.64%
Operating Income -370.16% -370.26% -370.59% -152.27% 257.49%
Income Before Tax -367.30% -368.31% -369.90% 504.69% 298.86%
Income Tax Expenses -100.00% -100.00% -100.00% -95.61% --
Earnings from Continuing Operations -407.08% -398.09% -400.65% 317.66% 273.10%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -407.08% -398.09% -400.65% 317.66% 273.10%
EBIT -370.16% -370.26% -370.59% -152.27% 257.49%
EBITDA -367.10% -366.85% -366.60% -137.87% 266.94%
EPS Basic -390.60% -390.00% -397.61% 756.84% 232.26%
Normalized Basic EPS -297.01% -313.30% -317.34% -44.86% 287.04%
EPS Diluted -393.01% -391.83% -399.55% 731.58% 231.32%
Normalized Diluted EPS -297.79% -314.00% -318.07% -46.13% 286.30%
Average Basic Shares Outstanding 3.22% 2.92% 2.53% 3.91% 12.39%
Average Diluted Shares Outstanding 3.17% 2.87% 2.48% 3.97% 12.44%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --